The United Kingdom Government has secured early access to 90 million vaccine doses to protect the UK from coronavirus.
Treatments containing COVID-19-neutralising antibodies have also been secured to protect those who cannot receive vaccines.
Business Secretary Alok Sharma announced that the Government has agreed on significant partnerships with leading pharmaceutical and vaccine companies BioNTech/Pfizer and Valneva developing innovative new vaccines to protect people against Covid-19.
The vaccine doses are from the BioNTech/Pfizer alliance and Valneva while the antibodies have been secured from AstraZeneca.
The public is being urged to sign up to a new NHS website to make it quicker and easier for potential volunteers to join vital studies that could help save lives.
The aim is to get 500,000 people signed up by October.